*Correspondence: Maria Teresa Baltazar, [email protected] Present address: Danilo Basili, Socit des Produits Nestl S.A., Nestl Research, Lausanne, Switzerland Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Clinical evidence linking semaglutide to joint inflammation reduction A 2023 observational study published in medical journals noted that patients taking GLP-1 agonists for weight management reported subjective improvement in joint pain and swelling
Beyond these, advanced interventions like nisin, an antimicrobial peptide produced by Lactococcus lactis , correct dysbiosis across oral, gut, and liver sites to prevent NAFLD steatosis (Kuraji et al., 2024)
Share: New research suggests that GLP-1 weight loss medications may provide major long-term benefits for heart health in addition to helping people lose weight and manage blood sugar
The molecule exists in two primary forms: reduced glutathione (GSH), which constitutes more than 98% of total glutathione under normal physiological conditions, and oxidized glutathione (GSSG)